Published in Drug Law Weekly, February 6th, 2007
"Our offer represents a superior proposal. Caremark stockholders and the marketplace as a whole have demonstrated their strong support for our offer, which clearly provides Caremark stockholders with superior value to the proposed acquisition of Caremark by CVS Corporation (CVS). The advantages of an Express Scripts-Caremark combination are compelling. We remain committed to pursuing a combination of our two companies to create superior value for our respective stockholders, plan...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.